Yingjie Zhang
+
Gender:Male
Education Level:Postgraduate (Doctoral)
Alma Mater:山东大学
Paper Publications
- [111] xuwenfang and Yingjie Zhang. Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase. Bioorg. Med. Chem., 2015.
- [112] Yingjie Zhang. Development of N-hydroxybenzamide derivatives with indole containing cap group as histone deacetylases inhibitors. Bioorg. Med. Chem., 2015.
- [113] xuwenfang and Yingjie Zhang. Discovery of a series of novel compounds with moderate anti-hepatitis C virus NS3 protease activity in vitro.. Bioorg. Med. Chem., 2015.
- [114] Yingjie Zhang. Synthesis and biological evaluation of novel histone deacetylases inhibitors with nitric oxide releasing activity. Bioorg. Med. Chem., 2015.
- [115] xuwenfang and Yingjie Zhang. Histone deacetylase inhibitors merged with protein tyrosine kinase inhibitors. Drug Discov. Ther., 2015.
- [116] xuwenfang and Yingjie Zhang. Design, Synthesis and Antitumor Evaluation of Novel Histone Deacetylase (HDAC) Inhibitors Equipped with Phenylsulfonylfuroxan Module as Nitric Oxide (NO) Donor. J. Med. Chem., 2015.
- [117] xuwenfang and Yingjie Zhang. Enhanced anticancer activity of 5-FU in combination with Bestatin: Evidence in human tumor-derived cell lines and an H22 tumor-bearing mouse. Drug Discov. Ther., 2015.
- [118] xuwenfang and Yingjie Zhang. Isoform-selective histone deacetylase inhibitors: the trend and promise of disease treatment. Epigenomics, 2015.
- [119] xuwenfang and Yingjie Zhang. VEGF signal system: the application of antiangiogenesis.. Curr. Med. Chem., 2014.
- [120] xuwenfang and Yingjie Zhang. Discovery of N-(3-((7H-purin-6-yl)thio)-4-hydroxynaphthalen-1-yl) -sulfonamide derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part III.. Bioorg. Med. Chem., 2014.